Teva Expected to Name AZ's Sorio as New CEO

Jul 12, 2017

Calcalist

AstraZeneca CEO Pascal Sorio, a veterinarian, is expected to become the next CEO of Teva Pharmaceuticals, according to an article in Calcalist, a financial website. Sorio, who was AZ's CEO for almost five years, made headlines in 2016 when shareholders protested his $17.3 million annual salary.

Sorio reportedly agreed to accept the position with a signing bonus of $15M to $20M, and an annual salary almost double what the predecessor CEO, Erez Vigodman, received--upward of $11 million.

Read the full story (translation may be required)

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments